THE BRIDGE HATTR AMYLOIDOSIS Trademark
THE BRIDGE HATTR AMYLOIDOSIS is a USPTO trademark filed by Alnylam Pharmaceuticals, Inc.. Status: Registered.
Trademark Facts
| Mark | THE BRIDGE HATTR AMYLOIDOSIS |
|---|---|
| Serial Number | 87795814 |
| Registration Number | 5665054 |
| Status | Registered |
| Filing Date | 2018-02-13 |
| Registration Date | 2019-01-29 |
| Mark Type | Combined |
| Nice Classes | 035 (Advertising & Business) |
| Owner | Alnylam Pharmaceuticals, Inc. |
| Attorney of Record | Sarah Anne Keefe |
| Prosecution Events | 30 |
| Latest Event | NA85 on 2024-09-06 |
Goods & Services
Class 035: Promoting public awareness about hATTR amyloidosis among affected individuals and their families